Searched for
GENERIC CAPSULE
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Marksans Pharma gets USFDA nod for generic Benzonatate capsulesMarksans Pharma has received final approval from the US Food and Drug Administration for its generic version of Benzonatate capsules used t...
- Sun Pharma gets USFDA nod to market generic medicationIn June 2021, Sun Pharma entered into a settlement with Celgene Corporation (Celgene) to resolve the patent litigation regarding its generi...
- Dr Reddy's launches generic Revlimid in US market"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bring...
- Dr Reddy's gets FDA nod for generic Revlimid; enjoys 180 days exclusivity"We are pleased with the Agency's approval of Lenalidomide Capsules, 2.5 mg and 20 mg and being eligible for 180-day market exclusivity. We...
- Unichem Labs gets USFDA nod to market generic capsulesThe company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg fr...
- Natco Pharma launches Tamiflu generic capsules in USThe company's capsules are generic versions of Roche's Tamiflu drug
- Dr Reddy's launches generic acid reflux drug in USThe company has launched the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg after the approval from the USFDA, Dr Reddy's Labo...
- Lupin gets USFDA nod for generic version of Mycobutin CapsulesThe approval from the US Food and Drug Administration is for Rifabutin Capsules USP, in strength of 150 mg, said Lupin in a statement.
- Lupin launches generic Fenofibric Acid capsules in US marketLupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...
- Dr Reddy's gets USFDA nod for generic Zenatane capsulesCompany has launched Accutane (Isotretinoin Capsules ) in the strengths of 20 mg and 40 mg on Mar 28 following the approval by the USFDA.
- Sun Pharma gets USFDA nod for generic cardiac capsulesDiltiazem HCl extended-release capsules are indicated for the treatment of hypertension and for the management of angina.
- Sun Pharma receives USFDA nod for generic Clarinex, TiazacSun Pharma has received approval from USFDA for its abbreviated new drug application to market a generic version of Schering Plough's Clari...
- Sun Pharma receives US FDA nod for hyperactivity drugIt has received approval to sell generic strattera capsules, used in treating attention deficit hyperactivity disorder, in the American mar...
- DRL, Novartis smoke peace pipe on Alzheimer's drugDr Reddy’s Laboratories (DRL) has entered a settlement agreement with Novartis Pharma to suspend the launch of its generic capsule rivastig...
Load More
